DISCLAIMER: This product may be a complementary medicine and/or not have been evaluated and verified by the South African Health Products Regulatory Authority for its quality, safety or intended use
The future direction of obesity treatment is poised for significant advancements with medical professionals, policymakers, and the pharmaceutical industry recognizing the urgent need for effective and safe weight-loss medications
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: A post-treatment analysis of a randomised placebo-controlled trial
Among participants, background use of GLP-1RA and SGLT2i was 5.8% and 8.9%, respectively, and treatment effect of finerenone on cardiovascular death was consistent regardless of those medication usages
So, the first step is having a conversation with your healthcare team
Understanding Each Component CJC-1295 (with DAC) CJC-1295 is a growth hormone releasing hormone (GHRH) analog that extends the half-life of naturally occurring GHRH